{"id":52167,"date":"2022-12-20T12:02:27","date_gmt":"2022-12-20T11:02:27","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-human-microbiome-market-analysis-to-2031-players-include-synthetic-biologics-ysopia-bioscience-4d-pharma-and-dupont-de-nemours-among-others-researchandmarkets-com\/"},"modified":"2022-12-20T12:02:27","modified_gmt":"2022-12-20T11:02:27","slug":"global-human-microbiome-market-analysis-to-2031-players-include-synthetic-biologics-ysopia-bioscience-4d-pharma-and-dupont-de-nemours-among-others-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-human-microbiome-market-analysis-to-2031-players-include-synthetic-biologics-ysopia-bioscience-4d-pharma-and-dupont-de-nemours-among-others-researchandmarkets-com\/","title":{"rendered":"Global Human Microbiome Market Analysis to 2031 – Players Include Synthetic Biologics, YSOPIA Bioscience, 4D Pharma and DuPont de Nemours Among Others – ResearchAndMarkets.com"},"content":{"rendered":"
\n

DUBLIN–(BUSINESS WIRE)–The “Global Human Microbiome Market Analysis 2021-2031”<\/a> report has been added to ResearchAndMarkets.com’s<\/strong> offering.\n<\/p>\n

<\/a><\/p>\n

\nThe global human microbiome market is anticipated to grow with a CAGR of 22.3% over the forecast period, i.e., 2022 – 2031.\n<\/p>\n

\nFactors such as the growing focus on microbiome therapeutics, followed by the surge in prevalence of lifestyle-related diseases, and the increasing research and developments on human microbiome are projected to add to the growth of the market in the coming years. The market is estimated to garner a revenue of near to USD 3250 Million by the end of 2031, up from a revenue of close to USD 440 Million in the year 2021.\n<\/p>\n

\nThe global human microbiome market is segmented by numerous segments which include segmentation by product, disease type, organism type, application, technology, and by region. By product, the market is segmented into probiotics, prebiotics, diagnostic tests, drugs, and others. By the end of 2031, the probiotics segment is anticipated to garner the largest revenue of about USD 1430 Million by the end of 2031. Additionally, in the year 2021, the segment generated a revenue of around USD 190 Million.\n<\/p>\n

\nOn the basis of regional analysis, the global human microbiome market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in North America, out of the market in all the other regions, is anticipated to garner the largest revenue of near to USD 1860 Million by the end of 2031. Additionally, in the year 2021, the market in the region generated a revenue of more than USD 250 Million.\n<\/p>\n

\nHowever, the stringent government regulations is expected to operate as key restraint to the growth of global human microbiome market over the forecast period.\n<\/p>\n

\nCompanies Mentioned<\/strong>\n<\/p>\n